Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Eli Lilly joins Remedium Bio's Series A financing, enhancing its portfolio in early-stage durable protein therapeutics.

PUBLIC · LLYAug 11, 2026about 3 hours ago

Round Type

Series A

IndianapolisManufacturingBiotechnologyHealth CarePharmaceutical

Description

Eli Lilly participated in Remedium Bio's Series A financing to expand its reach in the area of precision oncology and durable protein therapeutics. This move follows a strong Q2 2026 performance with significant revenue growth. The collaboration aligns with Eli Lilly's focus on innovative drug development. It highlights the company's strategy to diversify beyond its existing metabolic disease portfolio.

Company Information

Company

Eli Lilly

Location

Indianapolis, Indiana, United States

About

Eli Lilly is a global healthcare and pharmaceutical company focused on the discovery, development, and delivery of innovative pharmaceutical medicines, vaccines, and consumer healthcare products. It has a strong presence in the diabetes and obesity market segment and has been actively expanding its manufacturing network to meet the increasing demand for its medicines.

Related People

Suggested for you
5 contacts
Verified contactsSuresh K., Associate Director - Talent Acquisition hidden
Predictive Intelligence
Strategic

ML-powered predictions for Eli Lilly's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.